SuperworthNautilus Biotechnology market cap NAUT
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $412.3M
- Highest close in our data
- $992.8M
- Aug 2021
Nautilus Biotechnology is worth $412.3M at the close on Oct 23, 2026, at $3.24 a share.
That is up 168% over the last year and down 38% over five years.
Its highest close in our data was $992.8M in Aug 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $412.3M | $112.7M | $440.4M | +65% |
| 2025 | $250.1M | $83.5M | $284.2M | +17% |
| 2024 | $213.5M | $213.5M | $388.6M | −43% |
| 2023 | $373.6M | $222M | $497M | +66% |
| 2022 | $224.5M | $193.3M | $587.3M | −65% |
| 2021 | $643.2M | $143.5M | $992.8M | +209% |
| 2020 | $208.2M | $195.7M | $208.7M | n/a |
Against its peers
Companies in Medical - Diagnostics & Research nearest Nautilus Biotechnology's size, closest first, today.
| Company | Market cap |
|---|---|
| NAUTNautilus Biotechnology | $412.3M |
| NRCNRC Health | $485.1M |
| ICCCImmucell | $93.1M |
| CDNACareDx | $3.6B |
| VCYTVeracyte | $3.9B |
| Peer median | $2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Nautilus Biotechnology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.